Al B Benson
Northwestern University · Big Ten Cancer Research Consortium · ECOG-ACRIN Cancer Research Group
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Al B Benson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:45 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04713202 · Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat EthylChandrikha Chandrasekhara · withdrawn · Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea · study chair
- Ph2NCT03283761 · FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction AdenocarcinomaAl B. Benson, III, MD · completed · Gastro-Esophageal Junction Adenocarcinoma, Gastric Cancer · principal investigator
- Ph3NCT01004978 · Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryNational Cancer Institute (NCI) · completed · Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma · principal investigator
- Ph3NCT00217737 · Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerNational Cancer Institute (NCI) · completed · Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7, Stage IIB Colon Cancer AJCC v7 · principal investigator
- Ph1NCT00004090 · Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid TumorsNorthwestern University · completed · Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph2NCT00005607 · Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or EsophagusRobert H. Lurie Cancer Center · unknown · Esophageal Cancer, Gastric Cancer · study chair
- Ph3NCT00002551 · SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically RemovedSWOG Cancer Research Network · completed · Colorectal Cancer · study chair
- Ph1NCT00004913 · Combination Chemotherapy in Treating Patients With Advanced Solid TumorsNorthwestern University · completed · Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph1NCT00004095 · Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsNorthwestern University · completed · Bladder Cancer, Breast Cancer, Colorectal Cancer · study chair
- Ph3NCT00003216 · Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the PancreasRadiation Therapy Oncology Group · completed · Pancreatic Cancer · study chair
- Ph3NCT00003596 · Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerRadiation Therapy Oncology Group · completed · Anal Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Northwestern University Lead Academic Participating SiteUG1CA308665 · NCI · NORTHWESTERN UNIVERSITY · fiscal years 2026 · $1,492,954 awarded in 2026Same name and institution; not confirmed by an ID
- Protocol Review and Monitoring SystemP30CA060553 · NCI · NORTHWESTERN UNIVERSITY · fiscal years 1993 to 2026 · $121,422 awarded in 2026Same name and institution; not confirmed by an ID
- Northwestern University Lead Academic Participating SiteUG1CA233320 · NCI · NORTHWESTERN UNIVERSITY · fiscal years 2019 to 2025 · $463,643 awarded in 2025Same name and institution; not confirmed by an ID
- Real-World Data to Generate Real-World Evidence in Regulatory Decision-MakingU01FD007943 · FDA · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · fiscal years 2023 to 2024 · $2,247,715 awarded in 2024Same name and institution; not confirmed by an ID
- ECOG Clinical TrialsU10CA017145 · NCI · NORTHWESTERN UNIVERSITY · fiscal years 1991 to 2013 · $362,638 awarded in 2013Same name and institution; not confirmed by an ID
- NU 98X3: IRINOTECAN (CPT-11) AND GEMCITABINE IN PATIENTS WITH SOLID TUMORSM01RR000048 · NCRR · NORTHWESTERN UNIVERSITY · fiscal years 1987 to 2007 · $5,940 awarded in 2007Same name and institution; not confirmed by an ID
- THYMIDYLATE SYNTHASE EXPRESSION IN COLORECTAL CANCERR21CA067160 · NCI · NORTHWESTERN UNIVERSITY · fiscal years 1995 to 1996 · $157,439 awarded in 1996Same name and institution; not confirmed by an ID
- PHASE I & PHAMACOKINETIC STUDIES OF OLTIPRAZN01CN025527 · NCI · NORTHWESTERN UNIVERSITY · fiscal years 1992 to 1994Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Eastern Cooperative Oncology Group Operations OfficeU10CA021115 · NCI · FRONTIER SCI & TECHNOLOGY RSCH FDN, INC · PI ROBERT L COMIS · fiscal years 1985 to 2013Named on NCT01004978, NCT00217737
- ECOG-ACRIN Network Group Operations CenterU10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2014 to 2026Named on NCT01004978, NCT00217737
- Southwest Oncology Group Treatment GrantU10CA032102 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHARLES D. BLANKE · fiscal years 1985 to 2013Named on NCT00002551
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:45 UTC. The ranking covers the 200 most relevant of 58 PubMed records, and a shared surname and initials can bring in a namesake. All 58 on PubMed
- 1,815 citationsRCR 41.3
- 779 citationsRCR 25.4
- 657 citationsRCR 16.4
- 451 citationsRCR 12.1
- 439 citationsRCR 12.2
- 315 citationsRCR 7.7
- Impact of diabetes mellitus on outcomes in patients with colon cancer.J Clin Oncol · 2003294 citationsRCR 6.5
- Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.Cancer · 2003247 citationsRCR 5.7
- Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.J Clin Oncol · 2002226 citationsRCR 5.7
- Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.Clin Cancer Res · 2012222 citationsRCR 5.5